GWAS |
- Body fat percentage ( 31752434)
- Colonoscopy-negative controls vs population controls ( 29228715)
- Colorectal cancer ( 29228715)
- Femur bone mineral density x serum urate levels interaction ( 34046847)
- FEV1 ( 30804560)
- Height ( 28552196 31562340)
- Hip circumference adjusted for BMI ( 28552196)
- Low density lipoprotein cholesterol levels ( 33339817)
- Lung function (FEV1) ( 26635082 28166213)
- Lung function (FEV1/FVC) ( 30804560 26635082 28166213)
- Lung function (FVC) ( 30804560)
- Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics ( 32958699)
- Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892)
- Peak expiratory flow ( 30804560)
- Physiological traits ( 31902109)
- QT interval (sulfonylurea treatment interaction) ( 27958378)
- Systolic blood pressure night-to-day ratio in hypertension ( 29973135)
- Total cholesterol levels ( 33339817)
- Urate levels in obese individuals ( 25811787)
|
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Bipolar disorder ( 34002096)
- Diastolic blood pressure ( 30224653)
- Height ( 28552196)
- Obesity-related traits ( 23251661)
- Schizophrenia ( 25056061 29483656)
- White matter hyperintensity burden ( 25663218)
|